Every rule your marketing answers to.

Warrant reviews your marketing against 3,388 rules from 1,267 regulators across 11 countries. Every flag is cited to its source. Search the full library below.

Coverage includes the FTC, FDA, CFPB, SEC, FINRA, NCUA, FDIC, OCC, NAIC, and regulators from all 50 U.S. states, the European Union, Canada, and more.

Get a free homepage compliance scan

Regulation guides

CA Cosmetic Ingredient Disclosure Requirements

Cosmetics sold in California must carry an ingredient declaration on the label and must not be misbranded with false or unsupported safety claims.

Cal. Health & Safety Code § 111730; 21 CFR 701.3

CA PFAS-Free Cosmetics Act

California's PFAS-Free Cosmetics Act (AB 2771) bans the manufacture and sale of cosmetics containing intentionally added PFAS from Jan 1, 2025; it imposes no disclosure wording.

Cal. Health & Safety Code § 108981.5 (AB 2771, eff. Jan. 1, 2025); Cal. Bus. & Prof. Code § 17500

CA Proposition 65 - Supplements & Drugs

Prop 65 requires clear and reasonable warnings before California exposure to listed chemicals; dietary supplements use the food-warning safe harbor, warnings must name a chemical, and online sales must show the warning before purchase.

Cal. Health & Safety Code § 25249.6; 27 CCR §§ 25602, 25607.1, 25607.2

CA Toxic-Free Cosmetics Act Ingredient Bans

California bans the sale of cosmetics containing 24 listed ingredients and intentionally added PFAS from Jan 1, 2025, with more substances added by AB 496 from Jan 1, 2027.

Cal. Health & Safety Code § 108980(a)(1)-(12); Cal. Health & Safety Code § 108980(b); Cal. Health & Safety Code § 108981.5

EU Food Supplements Directive

EU food supplement marketing must not make medicinal claims, may use only authorised health claims, and labels and listings must carry the mandatory daily-dose, warning and varied-diet statements.

Directive 2002/46/EC Arts 6-7; Regulation (EC) 1924/2006 Arts 10, 12; Regulation (EU) 432/2012

FDA Cosmetic Labeling Requirements

Requires cosmetic labels to show identity, net quantity, ingredients, the responsible firm's name and place of business, and applicable warnings.

21 U.S.C. 362(b); 21 CFR 701.3, 701.11, 701.12, 701.13, 740.11

FDA Cosmetic Labeling Standards

Cosmetic labels must show identity, net quantity, an ingredient declaration in descending order, the responsible business's name and place, a MoCRA adverse-event contact, and required warnings.

21 CFR 701.3, 701.11, 701.12, 701.13; 21 CFR 740; FD&C Act 602, 609(a) (MoCRA)

FDA Cosmetics Advertising & Labeling (MoCRA)

Requires MoCRA's adverse-event contact information and professional-use statements on cosmetic labels and bars claims that a cosmetic is FDA approved.

21 U.S.C. 362, 364e (FD&C 602, 609)

FDA Cosmetics General Regulations

Cosmetics may not contain prohibited or restricted ingredients or unlisted colors, must carry 21 CFR 740 warnings where required, and may not make drug claims.

21 CFR 700.11-700.35; 21 CFR 73, 74, 82; 21 CFR 740; FD&C Act 201(i), 601, 602

FDA Dietary Supplement Advertising & Labeling (DSHEA)

Bars supplement disease claims and requires the DSHEA disclaimer with structure/function claims in labeling and a Supplement Facts panel on labels.

21 U.S.C. 343(r)(6); 21 CFR 101.93(c), (d), (g)(2)(i); 21 CFR 101.36(a), (b), (e)

FDA Dietary Supplement Claims

Bars supplement marketing that implies a disease effect through product names, images, testimonials, cited publications or disease symptoms.

21 U.S.C. 343(r)(6); 21 CFR 101.93(g)(2)(i), (ii), (iv)(A), (C), (E), (x)

FDA Dietary Supplement Health Claims

Bars supplement marketing that positions the product as a substitute for, enhancer of or equivalent to a drug or medical treatment.

21 U.S.C. 343(r)(6); 21 CFR 101.93(g)(2)(iv)(B), (vi), (vii), (x); 15 U.S.C. 45, 52

FDA Drug Definition Standards

Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.

21 U.S.C. 321(g)(1), 321(i), 343(r)(6); 21 CFR 101.93(g)(2)

FDA MoCRA Cosmetics Modernization — Marketing Claims

Cosmetic marketing must stay within cosmetic (appearance) claims, must not imply FDA approval, and cosmetic labels must include MoCRA adverse-event contact information.

21 U.S.C. 321(g)(1), 321(i), 362, 364e(a); 7 CFR 205.304(c), 205.311(a)

FDA MoCRA Cosmetics Registration Requirements

Under MoCRA, cosmetic labels must give a US address, US phone number or electronic contact for adverse-event reports, and professional-use products must say they are for licensed professionals only.

21 U.S.C. 364e (FD&C 609)

FDA Sports Nutrition DSHEA Compliance

Sports supplements may make structure/function claims only with the full FDA disclaimer on labeling and must not make disease or drug-equivalent claims.

21 U.S.C. 321(g)(1), 343(r)(6); 21 CFR 101.93(c), (d), (g)(2)

FDA Sunscreen Labeling Requirements

US OTC sunscreen labels and promotional copy must use monograph-permitted SPF, broad spectrum and water resistance statements, Drug Facts and required warnings, and avoid prohibited terms like sunblock and waterproof.

21 CFR 201.327, 201.66; 21 U.S.C. 355h

FDA Sunscreen Monograph Compliance

Sunscreen marketing must use monograph-consistent claims: no 'sunblock', 'waterproof', 'sweatproof', instant or all-day protection claims, water resistance only as 40 or 80 minutes, and broad-spectrum and skin-cancer claims only for qualifying products.

21 CFR 201.327; OTC Monograph M020

FDA Sunscreen OTC Drug Standards

OTC sunscreens may use only monograph-listed active ingredients within permitted concentrations, and labels must carry a complete Drug Facts panel and, where required, the Skin Cancer/Skin Aging Alert.

21 CFR 201.66; 21 CFR 201.327; OTC Monograph M020

FDA Supplement GMPs and New Dietary Ingredients

Supplement marketing may describe cGMP manufacturing accurately but may not claim FDA approval or certification of the product or facility, which FDA does not give.

21 CFR 111; FD&C Act 413 (21 U.S.C. 350b); FD&C Act 403(a); FTC Act 5, 12

FDA Weight Loss Product Labeling and Safety Standards

Weight-loss product marketing must avoid unrealistic or drug-equivalent claims and banned ingredients, disclose typical results for testimonials, and carry Supplement Facts and the DSHEA disclaimer on labeling.

21 U.S.C. 342(f)(1)(A), 343(a)(1), 343(r)(6); 21 CFR 101.36(a), (e)(1); 21 CFR 101.93(c), (d), (f), (g)(2); 21 CFR 119.1; 15 U.S.C. 45(a)(1), 52(a)-(b); 16 CFR 255.2(a)-(b)

FL Sunscreen Labeling Requirements — FL Stat § 499.85

Sunscreen labels and ads must avoid 'waterproof', 'sweatproof' and 'sunblock', use only 40- or 80-minute water-resistance claims, and limit skin-cancer claims to Broad Spectrum SPF 15+ products.

21 CFR 201.327(a)(2); 21 CFR 201.327(c)(2)-(3); 21 CFR 201.327(d)(2); 21 CFR 201.327(e)(3)-(4); 21 CFR 201.327(g)

FTC Cosmetics Advertising - Safety and Ingredient Claims

Cosmetic safety, testing, natural and organic claims must be substantiated and match the product's ingredients; USDA organic labeling requires certification.

15 U.S.C. 45, 52; FTC Policy Statements on Deception and Substantiation; 7 CFR 205.301, 205.303, 205.311

FTC Dietary Supplement Substantiation

Supplement marketing may not make disease or FDA-approval claims, health claims need competent and reliable scientific evidence, and labeling with structure/function claims must carry the FDA disclaimer.

15 U.S.C. 45(a)(1); 15 U.S.C. 52(a)-(b); FTC Health Products Compliance Guidance (Dec. 2022) s III.B; 21 U.S.C. 343(r)(6); 21 CFR 101.93(c)-(g)

FTC Sports Nutrition Advertising Standards

Sports nutrition ads must not make guaranteed or exaggerated performance or body-composition claims, and testimonials must disclose generally expected results.

FTC Act, 15 U.S.C. 45, 52; 16 CFR 255.2

NY Personal Care Product Safety Disclosures

New York personal care and cosmetic marketing must not make unqualified 'clean', 'non-toxic' or 'chemical-free' claims or free-of claims the product cannot support.

N.Y. GBL §§ 349, 350, 350-a; N.Y. Envtl. Conserv. Law § 37-0117

WA Toxic-Free Cosmetics Act

Washington's Toxic-Free Cosmetics Act bans cosmetics with intentionally added PFAS, ortho-phthalates, formaldehyde and releasers, mercury, phenylenediamines and lead above trace levels; assets must not offer such products in Washington or make chemical-free claims their ingredient lists contradict.

RCW 70A.560.020(1)(a)-(h); RCW 70A.560.020(2); RCW 70A.560.030(1), (4)

Browse by category

Browse by jurisdiction

Browse by regulator